Indication

Moraxella catarrhalis bronchitis

*Moraxella catarrhalis* bronchitis is a lower respiratory tract infection characterized by acute inflammation of the bronchial mucosa caused by the Gram-negative diplococcus *Moraxella catarrhalis*. Read more about Moraxella catarrhalis bronchitis

227 drugs 95 manufacturers

Advertisement

Drugs that treat it

Common Moraxella catarrhalis bronchitis therapies.

Showing 217–225 of 227 drugs

CEFDINIR

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+15
Major Pharamceuticals

CEFDINIR

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+15
REMEDYREPACK, I

CLARITHROMYCIN

MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
REMEDYREPACK, I

CLARITHROMYCIN

MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
SOLARIS PHARMA
Filter & compare in the drug finder →Opens the drug finder with Moraxella catarrhalis bronchitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Moraxella catarrhalis bronchitis.

*Moraxella catarrhalis* bronchitis is a lower respiratory tract infection characterized by acute inflammation of the bronchial mucosa caused by the Gram-negative diplococcus *Moraxella catarrhalis*.

While acute tracheobronchitis can develop in immunocompromised hosts, this infection predominantly manifests as an acute bacterial exacerbation of chronic bronchitis in older adults and individuals with pre-existing chronic obstructive pulmonary disease (COPD) or compromised mucociliary clearance.

Pathophysiologically, colonization and mucosal invasion trigger neutrophil-mediated airway inflammation, clinically presenting with increased dyspnea, worsening cough, and a marked increase in sputum volume and purulence.

Personalize your experience

Follow Moraxella catarrhalis bronchitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it